Eisai
4523.T
#1958
Rank
C$11.11 B
Marketcap
$39.41
Share price
-0.42%
Change (1 day)
-26.67%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.02. In 2022 the company made an earnings per share (EPS) of $2.22 a decrease over its 2021 EPS that were of $9.85.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9532.89%
2022$2.22-77.48%
2021$9.85-41.88%
2020$16.95-0.94%
2019$17.1152.59%
2018$11.21124.17%
2017$5.00-49.42%
2016$9.8937.08%
2015$7.21-11.75%
2014$8.17-3.23%
2013$8.45-18.56%
2012$10.37-15.51%
2011$12.28-3.75%
2010$12.76-1.36%
2009$12.93